BriaCell Therapeutics Corp Warrant
BCTXW
BCTXW was delisted on the 26th of February, 2026.
4 hedge funds and large institutions have $2.19M invested in BriaCell Therapeutics Corp Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
5.18% less ownership
Funds ownership: 9.96% → 4.79% (-5.2%)
33% less capital invested
Capital invested by funds: $3.29M → $2.19M (-$1.1M)
50% less funds holding
Funds holding: 8 → 4 (-4)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
88% less call options, than puts
Call options by funds: $278K | Put options by funds: $2.41M
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
M
Murchinson
Toronto,
Ontario, Canada
|
-$1.08M |
| 2 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$566K |
| 3 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
-$108K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.97K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$972 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $1.11M | +$3 | +1 | +0% |
|
|
KJHP
2
K.J. Harrison & Partners
Toronto,
Ontario, Canada
| $505K | -$108K | -37,626 | -18% |
|
|
PFM
3
Privium Fund Management
Amsterdam,
Netherlands
| $361K | -$566K | -196,876 | -62% |
|
|
RAM
4
Redmond Asset Management
Henrico,
Virginia
| $213K | – | – | – |
|
|
M
5
Murchinson
Toronto,
Ontario, Canada
| – | -$1.08M | -522,203 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$2.97K | -1,441 | Closed |
|
|
7
Bank of America
Charlotte,
North Carolina
| – | -$972 | -472 | Closed |
|
BCTXW Hedge Fund Activity: Q1 2023 in Review
4 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q1 2023, worth a combined $2.19M — down 33% from $3.29M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BCTXW and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Armistice Capital, adding an estimated $3. The largest seller was Murchinson, exiting entirely with an estimated $1.08M sold.
- 4 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q1 2023, down from 8 in Q4 2022.
- Funds reported $2.19M of BriaCell Therapeutics Corp Warrant stock for Q1 2023, down 33% quarter-over-quarter.
- 0 funds opened new BriaCell Therapeutics Corp Warrant positions in Q1 2023 and 3 closed out, a net change of -3 holders.
- The largest BriaCell Therapeutics Corp Warrant buyer in Q1 2023 was Armistice Capital, an estimated $3 added.
- The largest BriaCell Therapeutics Corp Warrant seller in Q1 2023 was Murchinson, an estimated $1.08M sold.
Based on aggregated 13F filings for Q1 2023.